Institutional investors purchased a net $3.3 million shares of CYTR during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 31.69% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 22.2 Thousand shares of CytRx Corp
CREATIVE PLANNING, INC. Bought 12.0 Thousand shares of CytRx Corp
PRINCIPAL MANAGEMENT CORP. Bought 11.2 Thousand shares of CytRx Corp